The Pharmacology of Indomethacin

@article{Lucas2016ThePO,
  title={The Pharmacology of Indomethacin},
  author={S. Lucas},
  journal={Headache: The Journal of Head and Face Pain},
  year={2016},
  volume={56}
}
  • S. Lucas
  • Published 2016
  • Medicine
  • Headache: The Journal of Head and Face Pain
    • Over 50 years ago, indomethacin emerged as an extremely potent non‐steroidal anti‐inflammatory drug (NSAID) during a massive effort to find effective anti‐inflammatory and analgesic medications. The 1960s saw acetic acid derivatives developed into indomethacin, diclofenac, and sulindac, and propionic derivatives into ibuprofen, naproxen, and ketoprofen. Indomethacin was likely the most potent of these compounds and one of the earliest to enter clinical trials. It is not surprising that… CONTINUE READING
    View on Wiley
    ncbi.nlm.nih.gov
    54 Citations
    Highly Influential Citations
    2
    Background Citations
    23
    Methods Citations
    1
    Results Citations
    1
    54 Citations
    Citation Type

    Citation Type

    Pyrrolidone-modified PAMAM dendrimers enhance anti-inflammatory potential of indomethacin in vitro.
    • 3
    Ameliorative effects of indomethacin at different concentrations on endothelial insulin resistance through two distinct pathways.
    • 1
    Indomethacin, a nonselective cyclooxygenase inhibitor, does not interact with MTEP in antidepressant-like activity, as opposed to imipramine in CD-1 mice.
    • K. Stachowicz
    • Chemistry, Medicine
    • European journal of pharmacology
    • 2020
    Continuing war on pain: a personalized approach to the therapy with nonsteroidal anti-inflammatory drugs and opioids.
    • 7
    • PDF
    Indomethacin increases severity of Clostridium difficile infection in mouse model.
    • 11
    Design of multicomponent indomethacin-paracetamol and famotidine loaded nanoparticles for sustained and effective anti-inflammatory therapy.
    Indomethacin-Responsive Headaches in Pediatric Age: Nosographic Aspects and Limitations on the use of Indomethacin in Pediatric Population
    • 1
    • PDF
    Combination of NSAID and Triptan in Migraine Treatment and Cardiovascular Risk: Is It Safe?
    INDOMETHACIN & SARS-COV-2: PROSPECTS FOR CLINICAL MANAGEMENT OF THE INFLAMMATORY STATE. Review
    • PDF
    Systemic bee venom exerts anti-arthritic and anti-inflammatory properties in a rat model of arthritis
    • PDF

    References

    SHOWING 1-10 OF 63 REFERENCES
    Suprofen: the pharmacology and clinical efficacy of a new non-narcotic peripheral analgesic.
    • 7
    A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches
    • 50
    Mechanism of action of antiinflammatory drugs.
    • 344
    Clinical Pharmacokinetics of Indomethacin
    • 131
    Mechanisms of action of anti-inflammatory drugs.
    • 117
    Are altered pharmacokinetics of non-steroidal anti-inflammatory drugs (NSAIDs) a risk factor for gastrointestinal bleeding?
    • 20
    Mechanism of action of anti-inflammatory drugs.
    • 324
    Indomethacin in rheumatoid arthritis: comparison of oral and rectal dosing.
    • 19
    Pharmacokinetic overview of indomethacin and sustained-release indomethacin.
    • K. Yeh
    • Medicine
    • The American journal of medicine
    • 1985
    • 36
    Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.
    • 18
    • PDF